AIDS and HIV Tuberculosis

Antiretroviral therapy can be deferred in stable patients

Published in TB and Outbreaks Week, March 26th, 2002

by Michael Greer, senior medical writer - HIV patients with tuberculosis should defer powerful antiretroviral treatments until the last stages of tuberculosis therapy if possible, researchers in the United Kingdom find.

"Many physicians delay HAART [highly active antiretroviral therapy] in patients presenting with TB because of pill burden, drug/drug interactions and toxicity," explained Dr. Gillian L. Dean and colleagues at St. Thomas' Hospital, St. George's Hospital, King's College Hospital, the Chelsea and Westminster Hospital, and University College Hospital in London and the Royal Sussex County Hospital in Brighton.

Dean and coauthors found...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-03-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry